Justin Yeh
Internal Medicine · Los Angeles, CANPI 1396373072
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.2% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,653, 2.5 times the $671 reported in 2023.
Across 122 payments — averaging $30.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$471
- AstraZeneca$287
- Novartis$236
- Karyopharm Therapeutics Inc.$215
- Sanofi$199
- Johnson & Johnson$174
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,44891%
- Education$3339%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $471 |
| AstraZeneca(2 entities) | 12 | $287 |
| Novartis | 9 | $236 |
| Karyopharm Therapeutics Inc. | 4 | $215 |
| Sanofi | 8 | $199 |
| Johnson & Johnson | 6 | $174 |
| EMD Serono, Inc. | 4 | $169 |
| Merck | 6 | $165 |
| Daiichi Sankyo Inc. | 7 | $163 |
| Blueprint Medicines Corporation | 5 | $150 |
| Bristol Myers Squibb | 6 | $146 |
| Argenx US, Inc. | 1 | $145 |
| Incyte Corporation | 5 | $142 |
| Gilead | 3 | $137 |
| Genentech USA, Inc. | 4 | $119 |
| Jazz Pharmaceuticals Inc. | 3 | $105 |
| Stemline Therapeutics Inc. | 3 | $88 |
| Servier Pharmaceuticals LLC | 3 | $73 |
| Eisai Inc. | 3 | $68 |
| Pfizer | 2 | $65 |
| Dendreon Pharmaceuticals LLC | 2 | $64 |
| Beone Medicines USA, Inc. | 2 | $53 |
| Aadi Bioscience, Inc. | 2 | $49 |
| Coherus Oncology, Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Syndax Pharmaceuticals, Inc. | 1 | $33 |
| Exelixis Inc. | 1 | $31 |
| Puma Biotechnology, Inc. | 1 | $30 |
| Amgen | 1 | $29 |
| Agios Pharmaceuticals, Inc. | 1 | $28 |
| Geron Corporation | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,781 in reported general payments places this provider in the 85th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Los Angeles
- William HardyLos Angeles$704K
- Soha DolatabadiLos Angeles$458K
- Matthew HerrmannLos Angeles$384K
- Koppany VisnyeiLos Angeles$287K
- Jaime BetancourtLos Angeles$286K
- William KingLos Angeles$227K
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.